How Much Do Peptides Cost?
Peptide pricing looks arbitrary until you know what you are looking at. The same compound at the same nominal quantity can differ by a factor of two between suppliers, and the cheapest option is not automatically the best value or the worst quality. This page explains what the numbers are made of.
The realistic ranges
Most single research vials fall between roughly $50 and $300. Where a specific compound lands depends on how hard it is to synthesize, how large the vial is, and how much testing the supplier pays for. As a concrete, dated example: in ourretatrutide supplier comparison, checked August 8, 2026, 10 mg vials ranged from $105 to $200, and price per milligram across all four suppliers ranged from $10.50 to $34.
That last figure is the point. A three-fold spread in price per milligram for the same compound, all sold openly, all claiming high purity.
Price per milligram is the only comparable number
Vial price is what suppliers advertise and it is close to meaningless on its own, because vial sizes are not standardized:
| Example vial | Sticker price | Price per mg | Which looks cheaper? |
|---|---|---|---|
| 5 mg | $170 | $34.00 | Lower sticker, far worse value |
| 10 mg | $200 | $20.00 | Higher sticker, better value |
| 10 mg | $105 | $10.50 | Best on both |
Multi-vial and bulk pricing usually moves cost per milligram more than switching suppliers does — and for compounds that are titrated across a wide dose range, the dose itself dominates everything: consumption at 12 mg weekly is six times consumption at 2 mg weekly, regardless of who you buy from.
What you are actually paying for
- Synthesis. Longer sequences and unusual modifications cost more to make. A 39-amino-acid compound is not priced like a tripeptide.
- Purification. Getting from crude product to ≥99% purity means additional HPLC purification steps and yield losses.
- Third-party testing. Lot-specific HPLC and mass spectrometry from a named laboratory costs real money per batch. Endotoxin and sterility testing cost more again, which is exactly why they appear less often on public COAs.
- Fill and finish. Sterile filtration, lyophilization, vialing under controlled conditions.
- Overheads. Cold-chain shipping, customer support, returns, and the margin the business runs on.
A supplier that skips the third and fourth items can be genuinely cheaper without doing anything illegal. They are also selling a different product than the one that includes them, and the label will not say so.
Why unusually cheap is a warning sign
Synthesis, purification and testing have a cost floor. A price well under everyone else's usually means one of the inputs was removed, and the plausible candidates are:
- Underfilled vials — 10 mg on the label, less in the glass.
- Lower purity — the truncated sequences and by-products that a further purification pass would have removed.
- A different compound entirely, or a partially degraded one.
- No real third-party testing behind the purity claim — a generic PDF instead of a lot-specific report.
None of these is visible in a vial of white powder. The only defense is documentation: a lot number that matches your vial, a named laboratory, a report date, HPLC for purity and mass spectrometry for identity. Oursupplier evaluation guide covers how to read one properly.
Costs people forget
- Bacteriostatic water — modest, but necessary; see our guide to what the label says.
- Syringes and alcohol pads.
- Waste. A vial that reaches the end of its stability window unfinished was money spent on nothing — a real cost with dilute reconstitution and small doses.
- Shipping, particularly where cold-chain handling is offered.
Compared with approved medicines
| Option | Approximate monthly cost | Supervision | Quality assurance |
|---|---|---|---|
| Clinical trial participation | $0 | Full | Pharmaceutical grade |
| Research-grade material | Tens to a few hundred dollars | None | Supplier documentation only |
| Semaglutide (Wegovy, list) | ~$1,300 | Full | FDA approved |
| Tirzepatide (Zepbound, list) | ~$1,060 | Full | FDA approved |
List prices move and manufacturer savings programs bring real-world cost substantially below them — check the manufacturer's page for the current figure rather than trusting any number on a third-party site, including this one. The structural point survives the details: what the gray market saves in money it gives up in supervision and in any regulatory guarantee about the contents of the vial.
Frequently asked questions
How much do research peptides cost?
Most single vials sit somewhere between roughly $50 and $300, depending on the compound, the vial size and the supplier. In our retatrutide supplier comparison, checked August 8, 2026, 10 mg vials ranged from $105 to $200 — a near-doubling for the same nominal quantity of the same compound.
Why is price per milligram the number that matters?
Because vial sizes differ between vendors. A $170 vial containing 5 mg is far more expensive than a $200 vial containing 10 mg, even though the sticker says otherwise. Dividing price by milligrams puts every supplier on one axis.
Why is one supplier so much cheaper than another?
Legitimately: scale, bulk synthesis contracts, thinner margins, less testing. Illegitimately: underfilled vials, lower purity, a different or partly degraded compound, or no real third-party testing behind the purity claim. The price alone does not tell you which, which is why documentation matters more than the number.
Is expensive peptide better quality?
Not reliably. Price correlates loosely with testing investment at best, and there is no shortage of expensive material with thin documentation. Published lot-specific COAs from a named laboratory are the signal; price is not.
How does research-grade pricing compare to approved medicines?
Approved incretin medicines list at roughly $1,000–1,300 per month before insurance and manufacturer savings programs. Research-grade material is a fraction of that. The gap is the entire reason a gray market exists — and what it buys is the absence of a prescriber, a label, and any regulatory evaluation of what is in the vial.
Sources
- Vendor prices recorded from public product pages on August 8, 2026 — see the retatrutide supplier comparison for the underlying table and methodology.
- Manufacturer self-pay pricing, checked 2026: Wegovy (NovoCare) and Zepbound (Lilly).
- FDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA
Related guides
- How to evaluate a peptide supplier
- Retatrutide supplier comparison with price per mg
- How to reconstitute peptides
- Peptide reconstitution calculator